"I think it's important here that we notice that we the public, we the people, developed this drug. We paid for this drug, we led and developed all the patents to create PrEP," the progressive congresswoman from New York explained.
Gottlieb has made the process faster and more transparent and the changes are already bearing fruit.
Taking PrEP can reduce the risk of contracting HIV by more than 90 percent.
A pill meant to prevent HIV infections in high-risk individuals appears to be working, according to two new studies.
An insurance company reports patients on preexposure prophylaxis (PrEP) have remained free of the virus.
Tensions rise over a prophylactic drug treatment for HIV infection